Table 1.
MIC50 and MIC90 values and percent antimicrobial resistance for A. baumannii and P. aeruginosa clinical isolates
Antimicrobial agent | |
A. baumannii (n = 101) |
P. aeruginosa (n = 15) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Breakpoint forresistancea (mg/L) | %Resistance | Range(mg/L) | MIC50(mg/L) | MIC90(mg/L) | Breakpoint forresistancea (mg/L) | %Resistance | Range(mg/L) | MIC50(mg/L) | MIC90(mg/L) | |
Amikacin |
≥64 |
85 |
<2- > 1024 |
>1024 |
>1024 |
≥64 |
60 |
<2- > 1024 |
64 |
>1024 |
Arbekacin |
- |
- |
<2- > 1024 |
>1024 |
>1024 |
- |
- |
2- > 1024 |
2 |
>1024 |
Aztreonam |
- |
- |
<2- > 256 |
128 |
>256 |
≥32 |
46 |
4- > 256 |
16 |
>256 |
Ceftazidime |
≥32 |
55 |
<4- > 512 |
>512 |
>512 |
≥32 |
46 |
<4- > 512 |
16 |
>512 |
Ciprofloxacin |
≥4 |
98 |
<1- > 128 |
128 |
>128 |
≥4 |
66 |
<1-64 |
8 |
32 |
Colistin |
≥4 |
6 |
<0.25-4 |
2 |
2 |
≥8 |
0 |
<0.25-0.5 |
<0.25 |
0.5 |
Gentamicin |
≥16 |
91 |
<2- > 1024 |
>1024 |
>1024 |
≥16 |
66 |
<2- > 1024 |
256 |
>1024 |
Imipenem |
≥16 |
48 |
<4-128 |
16 |
32 |
≥8 |
53 |
<4-64 |
16 |
32 |
Meropenem |
≥16 |
51 |
<4- > 256 |
32 |
64 |
≥8 |
53 |
<4-32 |
16 |
32 |
Piperacillin |
≥128 |
100 |
<4- > 512 |
>512 |
>512 |
≥128 |
46 |
<4- > 512 |
32 |
256 |
Piperacillin/Tazobactam | ≥128/4 | 52 | <4- > 512 | 256 | 512 | ≥128/4 | 13 | <4-512 | 32 | 128 |
aBreakpoints for antimicrobial resistance were determined according to the guidelines of the Clinical and Laboratory Standards Institute (M07-A9).